Biomarkers, such as glucose, insulin, lipids, and liver enzymes, have been quantitatively analyzed for the diagnosis and follow-up of metabolic disorders, including diabetes mellitus, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD) [106]. The gene discussed is INS; the disease is metabolic disease.